MAGI's Lab, Rovereto (TN), Italy.
Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7582-7598. doi: 10.26355/eurrev_201909_18880.
Familial atrial fibrillation (FAF), a not uncommon arrhythmia of the atrium, is characterized by heritability, early onset and absence of other heart defects. The molecular and genetic basis is still not completely clear and genetic diagnosis cannot be achieved in about 90% of patients. In this study, we present the results of genetic screening by next generation sequencing in affected Russian families.
Sixty subjects (18 probands and 42 relatives) with a clinical diagnosis of FAF were enrolled in the study. Since AF frequently associates with other cardiomyopathies, we included all genes that were known to be associated with these disorders at the time of our study. All probands were therefore systematically screened for 47 genes selected from the literature.
Our study revealed that seven variants co-segregated with the clinical phenotype in seven families. Interestingly, four out of six genes and three out of seven variants have already been associated with Brugada syndrome in the literature.
To our knowledge, this is the first report of association of the CACNA1C, CTNNA3, PKP2, ANK2 and SCN10A genes with FAF; it is also the first study in Russian families.
家族性心房颤动(FAF)是一种常见的心房心律失常,其特征为遗传性、发病早且无其他心脏缺陷。其分子和遗传基础仍不完全清楚,约 90%的患者无法进行基因诊断。本研究报告了对受影响的俄罗斯家族进行下一代测序遗传筛查的结果。
本研究纳入了 60 名(18 名先证者和 42 名亲属)临床诊断为 FAF 的患者。由于 AF 常与其他心肌病相关,因此我们纳入了当时已知与这些疾病相关的所有基因。因此,所有先证者都从文献中选择了 47 个基因进行系统筛查。
我们的研究表明,在 7 个家族中,7 个变体与临床表型共分离。有趣的是,6 个基因中有 4 个和 7 个变体中有 3 个已经在文献中与 Brugada 综合征相关。
据我们所知,这是 CACNA1C、CTNNA3、PKP2、ANK2 和 SCN10A 基因与 FAF 相关的首次报道,也是俄罗斯家族的首次研究。